Navigation Wealth Management’s Pfizer PFE Stock Holding History

Navigation Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-416	Closed	-$18K	–	35
2022 Q3	$18K	Hold	416	–	–	1.94%	10
2022 Q2	$22K	Hold	416	–	–	2.44%	7
2022 Q1	$22K	Hold	416	–	–	0.21%	10
2021 Q4	$24K	Hold	416	–	–	0.02%	26
2021 Q3	$18K	Hold	416	–	–	0.12%	23
2021 Q2	$16K	Hold	416	–	–	0.01%	35
2021 Q1	$15K	Buy	+416	New	+$14.8K	0.02%	31

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Navigation Wealth Management's PFE Position: Q4 2022 in Review

Navigation Wealth Management sold out of Pfizer (PFE) in Q4 2022, closing a stake of 416 shares — an estimated $18K sold.

Navigation Wealth Management first reported a position in PFE in Q1 2021 and held it in 7 quarters. The position peaked at $24K in Q4 2021. 3,265 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

Navigation Wealth Management reported no remaining Pfizer position as of Q4 2022 after selling out during the quarter.
Navigation Wealth Management sold 416 Pfizer shares in Q4 2022, an estimated $18K.
Navigation Wealth Management first reported a position in Pfizer in Q1 2021 and held it in 7 quarters.
Navigation Wealth Management's Pfizer position peaked at $24K in Q4 2021.
3,265 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on Navigation Wealth Management's 13F filing for Q4 2022, filed 6 Jan 2023.